Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM36G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,467 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Skyrizi 360 mg/2.4 mL on-body injector units. The contract, executed on January 8, 2026, with a completion date of January 30, 2026, represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. This prime IDC, valued at up to $999.99 million through December 2031, serves as the vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. The award utilized competitive procurement procedures with no set-aside designation, reflecting open competition among eligible vendors.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly for Department of Defense and military healthcare systems. Skyrizi is a biologic immunosuppressant medication used in the treatment of inflammatory conditions such as psoriasis and Crohn's disease. The on-body applicator format represents an advanced drug delivery mechanism designed for patient convenience and healthcare system efficiency. This delivery order exemplifies the company's ongoing role in supplying specialized pharmaceutical products to support military treatment facilities and federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FM36G?
SPE2DR26FM36G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FM36G worth?
The government has obligated $12,467 on SPE2DR26FM36G.
Is contract SPE2DR26FM36G an order under another contract?
Yes. SPE2DR26FM36G is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM36G competed?
The extent of competition for SPE2DR26FM36G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award